Home › Funds › Two Sigma Investments › DMAC
Two Sigma Investments position in DMAC
DIAMEDICA THERAPEUTICS INC · Health Care
Latest position (Q4 2022)12.15K sh
Reported value held$19.20K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 74.28K | $298.00K | New |
| Q4 2021 | 140.86K | $525.00K | Add |
| Q1 2022 | 50.07K | $125.00K | Reduce |
| Q2 2022 | 17.25K | $35.00K | Reduce |
| Q3 2022 | 14.52K | $18.00K | Reduce |
| Q4 2022 | 12.15K | $19.20K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding DMAC
- BlackRock Inc 2.25M sh · $15.86M · Q2 2026
- Geode Capital Management 894.12K sh · $6.30M · Q2 2026
- Millennium Management 845.31K sh · $5.95M · Q2 2026
- Vanguard Group 723.12K sh · $5.76M · Q4 2025
- Northern Trust Corp 327.52K sh · $2.31M · Q2 2026
- Goldman Sachs Group 168.07K sh · $1.18M · Q2 2026
- Citadel Advisors 145.87K sh · $1.03M · Q2 2026
- BNY Mellon 117.82K sh · $829.45K · Q2 2026
- Charles Schwab Investment Management 96.69K sh · $680.71K · Q2 2026
- Bank of America Corp 57.71K sh · $406.29K · Q2 2026
- Morgan Stanley 46.87K sh · $329.99K · Q2 2026
- Wells Fargo & Co 36.93K sh · $259.97K · Q2 2026